Frank D Buono (Frank Buono)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Inflammatory Response

Top Venues

Acta psychiatrica Scandinavica

American journal of medical genetics. Part A

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Amir Garakani, Frank D Buono, Mona Salehi, Melissa C Funaro, Anna Klimowicz, Harshit Sharma, Clara G F Faria, Kaitlyn Larkin, Rafael Christophe Freire
Antipsychotic agents in anxiety disorders: An umbrella review. Acta psychiatrica Scandinavica (2024)
Amir Garakani, Frank D Buono, Mona Salehi, Melissa C Funaro, Anna Klimowicz, Harshit Sharma, Clara G F Faria, Kaitlyn Larkin, Rafael Christophe Freire
Antipsychotic agents in anxiety disorders: An umbrella review. Acta psychiatrica Scandinavica 149 (4) (2024)
Frank D Buono, Kaitlyn Larkin, William T Zempsky, Lauretta E Grau, Staci Martin
Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM). American journal of medical genetics. Part A 194 (6) (2024)
Frank D Buono, Kaitlyn Larkin, William T Zempsky, Lauretta E Grau, Staci Martin
Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM). American journal of medical genetics. Part A 194 (6) (2024)
Amir Garakani, Frank D Buono, Mona Salehi, Melissa C Funaro, Anna Klimowicz, Harshit Sharma, Clara G F Faria, Kaitlyn Larkin, Rafael Christophe Freire
Antipsychotic agents in anxiety disorders: An umbrella review. Acta psychiatrica Scandinavica 149 (4) (2024)
Frank D Buono, Kaitlyn Larkin, William T Zempsky, Lauretta E Grau, Staci Martin
Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM). American journal of medical genetics. Part A 194 (6) (2024)
Amir Garakani, Frank D Buono, Mona Salehi, Melissa C Funaro, Anna Klimowicz, Harshit Sharma, Clara G F Faria, Kaitlyn Larkin, Rafael Christophe Freire
Antipsychotic agents in anxiety disorders: An umbrella review. Acta psychiatrica Scandinavica 149 (4) (2024)
Frank D Buono, Kaitlyn Larkin, William T Zempsky, Lauretta E Grau, Staci Martin
Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM). American journal of medical genetics. Part A (2024)
Amir Garakani, Frank D Buono, Mona Salehi, Melissa C Funaro, Anna Klimowicz, Harshit Sharma, Clara G F Faria, Kaitlyn Larkin, Rafael Christophe Freire
Antipsychotic agents in anxiety disorders: An umbrella review. Acta psychiatrica Scandinavica 149 (4) (2024)
Frank D Buono, Kaitlyn Larkin, Quynh Pham, Diane De Sousa, William T Zempsky, Chitra Lalloo, Jennifer Nan Stinson
Maintaining Engagement in Adults with Neurofibromatosis Type 1 to Use the iCanCope Mobile Application (iCanCope-NF). Cancers 15 (12) (2023)
Frank D Buono, Kaitlyn Larkin, Quynh Pham, Diane De Sousa, William T Zempsky, Chitra Lalloo, Jennifer Nan Stinson
Maintaining Engagement in Adults with Neurofibromatosis Type 1 to Use the iCanCope Mobile Application (iCanCope-NF). Cancers 15 (12) (2023)
Matthew E Sprong, Andres Chamarro, Maxim Polonsky, Ashley A Pechek, Cindy Pilcher, Mark D Griffiths, Frank D Buono
The Spanish Version of the Video Game Functional Assessment-Revised. Cyberpsychology, behavior and social networking 25 (7) (2022)
Amanda Fialk, Alexa Connors, Brianna Cerrito, Karee Jones, Frank D Buono
The Impact of SARS-CoV-2 (COVID-19) on the Acuity of Mental Health-Related Diagnosis at Admission for Young Adults in New York City and Washington, DC: Observational Study. JMIR formative research 6 (7) (2022)
Frank D Buono, Colette Gleed, Martin Boldin, Allison Aviles, Natalie Wheeler
Preliminary Effectiveness of a Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality: Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (1) (2022)
Frank D Buono, Matthew E Sprong, Erina Paul, Staci Martin, Kaitlyn Larkin, Amir Garakani
The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1. Orphanet journal of rare diseases 16 (1) (2021)